Search research articles
Contact Us
Filters
Showing results (321-330 of 362) with videos related to
Page
of 37
Sort By:
The Biochemical Journal
|
December 21, 2017
Identification of a second binding site on the TRIM25 B30.2 domain
Akshay A D'Cruz, Nadia J Kershaw, Thomas J Hayman, et al.
Nature Communications
|
June 10, 2022
Orgo-Seq integrates single-cell and bulk transcriptomic data to identify cell type specific-driver genes associated with autism spectrum disorder
Elaine T Lim, Yingleong Chan, Pepper Dawes, et al.
Science Advances
|
March 6, 2021
PD-L1<sup>+</sup> neutrophils contribute to injury-induced infection susceptibility
Ajitha Thanabalasuriar, Abby J Chiang, Christopher Morehouse, et al.
Frontiers in Molecular Biosciences
|
July 30, 2021
Small Molecule Microcrystal Electron Diffraction for the Pharmaceutical Industry-Lessons Learned From Examining Over Fifty Samples
Jessica F Bruhn, Giovanna Scapin, Anchi Cheng, et al.
JCI Insight
|
June 15, 2017
Mitochondrial dysregulation and glycolytic insufficiency functionally impair CD8 T cells infiltrating human renal cell carcinoma
Peter J Siska, Kathryn E Beckermann, Frank M Mason, et al.
ESMO Open
|
November 8, 2025
Second-line 5-FU plus nanoliposomal irinotecan versus FOLFOX/XELOX in metastatic pancreatic cancer after gemcitabine-nab-paclitaxel failure: a propensity score-matched analysis
G Trovato, D Rossini, A Guidolin, et al.
American Journal of Respiratory Cell and Molecular Biology
|
January 13, 2025
Novel Immune Response Evasion Strategy to Redose Adeno-associated Viral Vectors and Prolong Survival in Surfactant Protein-B Deficient Mice
Martin H Kang, Sylvia P Thomas, Caralyn Westley, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 30, 2015
A KRAS mutation status-stratified randomized phase II trial of gemcitabine and oxaliplatin alone or in combination with cetuximab in advanced biliary tract cancer
J S Chen, C Hsu, N J Chiang, et al.
ESMO Open
|
January 26, 2025
Corrigendum to "Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with biliary tract cancer": [ESMO Open 9 (2024) 103647]
L-T Chen, A Vogel, C Hsu, et al.
ESMO Open
|
September 4, 2024
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with biliary tract cancer
L-T Chen, A Vogel, C Hsu, et al.
Page
of 37
Search research articles
Search
Showing results (321-330 of 362) with videos related to
Sort By:
Page
of 37
The Biochemical Journal
|
December 21, 2017
Identification of a second binding site on the TRIM25 B30.2 domain
Akshay A D'Cruz, Nadia J Kershaw, Thomas J Hayman, et al.
Nature Communications
|
June 10, 2022
Orgo-Seq integrates single-cell and bulk transcriptomic data to identify cell type specific-driver genes associated with autism spectrum disorder
Elaine T Lim, Yingleong Chan, Pepper Dawes, et al.
Science Advances
|
March 6, 2021
PD-L1<sup>+</sup> neutrophils contribute to injury-induced infection susceptibility
Ajitha Thanabalasuriar, Abby J Chiang, Christopher Morehouse, et al.
Frontiers in Molecular Biosciences
|
July 30, 2021
Small Molecule Microcrystal Electron Diffraction for the Pharmaceutical Industry-Lessons Learned From Examining Over Fifty Samples
Jessica F Bruhn, Giovanna Scapin, Anchi Cheng, et al.
JCI Insight
|
June 15, 2017
Mitochondrial dysregulation and glycolytic insufficiency functionally impair CD8 T cells infiltrating human renal cell carcinoma
Peter J Siska, Kathryn E Beckermann, Frank M Mason, et al.
ESMO Open
|
November 8, 2025
Second-line 5-FU plus nanoliposomal irinotecan versus FOLFOX/XELOX in metastatic pancreatic cancer after gemcitabine-nab-paclitaxel failure: a propensity score-matched analysis
G Trovato, D Rossini, A Guidolin, et al.
American Journal of Respiratory Cell and Molecular Biology
|
January 13, 2025
Novel Immune Response Evasion Strategy to Redose Adeno-associated Viral Vectors and Prolong Survival in Surfactant Protein-B Deficient Mice
Martin H Kang, Sylvia P Thomas, Caralyn Westley, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 30, 2015
A KRAS mutation status-stratified randomized phase II trial of gemcitabine and oxaliplatin alone or in combination with cetuximab in advanced biliary tract cancer
J S Chen, C Hsu, N J Chiang, et al.
ESMO Open
|
January 26, 2025
Corrigendum to "Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with biliary tract cancer": [ESMO Open 9 (2024) 103647]
L-T Chen, A Vogel, C Hsu, et al.
ESMO Open
|
September 4, 2024
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with biliary tract cancer
L-T Chen, A Vogel, C Hsu, et al.
Page
of 37